Standards & Testing

Practical guide to building the critical-task matrix for auto-injector and pen-injector human factors validation — task identification from URRA, needle shield removal, site selection, dose confirmation, hold time, misfire recovery, training decay, disposal, use-error root cause analysis, and FDA/IEC 62366 evidence expectations.

Step-by-step guide to building the ASCA evidence package for 510(k) and De Novo submissions — ASCA Summary Test Report, declaration of conformity, lab accreditation status check, scope matching, withdrawn/suspended lab risk, FDA questions, and submission rescue strategies.

Practical due-diligence checklist for evaluating the FDA Third Party Review (3P510k) Program — product-code eligibility verification, Accredited Person selection, conflict-of-interest screening, eSTAR compatibility, FDA final-determination risk, timeline and cost tradeoffs, and when to avoid third-party review.

A comprehensive guide to IEC 62304 Edition 2 — the 2026 update replacing safety classes A/B/C with rigor levels, expanding scope to all health software, adding AI/ML lifecycle requirements, integrating cybersecurity, and practical compliance timelines for medical device manufacturers.

How Good Clinical Practice applies to medical device clinical trials — navigating ISO 14155:2026 and ICH E6(R3), sponsor and investigator responsibilities, informed consent, safety reporting, and audit readiness.

Protocol-level guide to cleaning validation for reusable surgical instruments — covering artificial soil selection, protein/hemoglobin/TOC endpoints, worst-case device families, manual vs automated cleaning, ANSI/AAMI ST98 acceptance criteria, sample size justification, and report structure.

Practical guide to using digital twins, synthetic data, and computational modeling in medical device regulatory submissions — covering FDA CM&S credibility guidance, ASME V&V 40, in silico clinical trials, synthetic control arms, model validation pitfalls, and documentation strategies.

Protocol-level analytical validation guide for IVD manufacturers — covering test plan tables, acceptance criteria, sample selection, statistical methods per CLSI standards, and FDA/EU IVDR expectations for analytical performance evidence.

Regulatory and risk assessment guide for medical devices incorporating nanomaterials — covering EU MDR Rule 19 classification, FDA nanotechnology guidance, ISO 10993-22 biocompatibility, SCENIHR exposure framework, nanotoxicology testing, sterilization challenges, labeling requirements, and a decision tree for regulatory strategy.

Comprehensive regulatory strategy guide for pre-filled syringes and auto-injectors as drug-device combination products — covering FDA OCP/RFD jurisdiction, ISO 11608 design verification, human factors validation, EU MDR Article 117, QMSR quality system implications, stability testing, and lifecycle change management.

Comprehensive supplier audit checklist for medical device manufacturers — covering supplier risk classification, qualification, audit agenda, purchasing controls per ISO 13485 Clause 7.4 and FDA QMSR, quality agreements, outsourced sterilization/testing/software, CAPA follow-up, and evidence records.

Equipment and process validation guide for washer-disinfectors in medical device reprocessing — covering ISO 15883 series parts 1–7, IQ/OQ/PQ methodology, A₀ value concept, load configurations, chemical dosing, temperature monitoring, microbiological endpoints, maintenance, and deviation handling.

How to select an ISO 17025 accredited testing laboratory for medical device biocompatibility, EMC, safety, and sterilization testing — including FDA ASCA program, scope verification, and cost considerations.

Complete guide to ASTM D4169 performance testing for medical device packaging — distribution cycle selection (DC-13, DC-6, DC-12), assurance levels (I, II, III), test schedules (drop, compression, vibration, low pressure, impact), pre-conditioning per ASTM D4332, relationship to ISO 11607 sterile barrier validation, FDA 510(k) requirements, sample size justification, acceptance criteria development, common pitfalls, and step-by-step implementation guide.

How to perform Fault Tree Analysis under ISO 14971 for medical devices — FTA vs FMEA comparison, AND/OR gate logic, quantitative probability calculations, real-world examples, and when top-down analysis outperforms bottom-up methods.

Practical guide to sample size calculation and justification for medical device clinical investigations — ISO 14155:2026 requirements, EU MDR Annex XV expectations, FDA IDE statistical guidance, superiority vs non-inferiority vs equivalence designs, Bayesian approaches, adaptive sample size re-estimation, pilot study sizing, and worked examples for orthopedic, cardiovascular, and diagnostic accuracy studies.

Comprehensive guide to developing a Statistical Analysis Plan (SAP) for medical device clinical trials — ICH E9 and E9(R1) estimand framework, primary and secondary endpoint hierarchy, analysis populations (ITT, PP, safety), missing data strategies (MI, tipping-point), sensitivity and supplementary analyses, multiplicity adjustment, SAP timing and approval, and regulatory expectations from FDA, EMA, and EU MDR for device submissions.

A complete guide to IEC 62133 battery safety compliance for medical devices — test requirements, regulatory pathways (FDA, EU MDR), UN 38.3 transport, Battery Management Systems, risk management, and practical steps for global market access.

A comprehensive guide to wireless and RF regulatory compliance for connected medical devices — FCC equipment authorization, EU Radio Equipment Directive (RED), wireless coexistence testing, cybersecurity requirements, risk management, and global market access strategies.

How to perform bacterial endotoxin testing (BET) for medical devices — LAL gel-clot, chromogenic, and turbidimetric methods, recombinant Factor C (rFC), USP <85>/<161>, ISO 11737-3, FDA 2026 pyrogen guidance update, endotoxin limits by device type, method selection, and regulatory submissions.